Guangzhou LBP Medicine Science & Technology Co., Ltd.

SHSE:688393 Stock Report

Market Cap: CN¥1.7b

Guangzhou LBP Medicine Science & Technology Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Xiangting Cai

Chief executive officer

CN¥965.1k

Total compensation

CEO salary percentagen/a
CEO tenure10.8yrs
CEO ownership35.0%
Management average tenure4yrs
Board average tenure4yrs

Recent management updates

Recent updates

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit

Nov 06
Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Shares May Have Run Too Fast Too Soon

Sep 30
Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Shares May Have Run Too Fast Too Soon

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 29
Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%

Apr 23
Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings

Mar 09
Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings

CEO

Xiangting Cai (60 yo)

10.8yrs

Tenure

CN¥965,100

Compensation

Mr. Xiangting Cai serves as Chairman of the Board at Guangzhou LBP Medicine Science & Technology Co., Ltd. (formerly known as LBP Medicine Science & Technology Co., Ltd) and serves as its General Manager....


Leadership Team

NamePositionTenureCompensationOwnership
Xiangting Cai
Chairman of the Board & GMno dataCN¥965.10k35.02%
CN¥ 593.8m
Shaoyu Chen
Deputy GM & Director4yrsCN¥525.50k0.0089%
CN¥ 150.4k
Zhefeng Deng
Deputy GM & Director4yrsCN¥800.90k0.011%
CN¥ 178.0k
Zongsheng Liang
Deputy GM & Director10.8yrsCN¥693.50k0.013%
CN¥ 222.4k
Aiping Huang
Accounting Supervisorno datano datano data

4.0yrs

Average Tenure

44.5yo

Average Age

Experienced Management: 688393's management team is considered experienced (4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Xiangting Cai
Chairman of the Board & GM10.8yrsCN¥965.10k35.02%
CN¥ 593.8m
Shaoyu Chen
Deputy GM & Director4yrsCN¥525.50k0.0089%
CN¥ 150.4k
Zhefeng Deng
Deputy GM & Director4yrsCN¥800.90k0.011%
CN¥ 178.0k
Zongsheng Liang
Deputy GM & Director10.8yrsCN¥693.50k0.013%
CN¥ 222.4k
Haijiao Wang
Director7.1yrsno data0.075%
CN¥ 1.3m
Xiang Wu
Independent Director4yrsCN¥80.00kno data
Hongri Wu
Independent Director4yrsCN¥80.00kno data
Xinglun Cai
Directorless than a yearCN¥765.20kno data
Shangcan Lin
Supervisorless than a yearno data0.00061%
CN¥ 10.3k
Wenping Peng
Independent Directorless than a yearno datano data

4.0yrs

Average Tenure

45yo

Average Age

Experienced Board: 688393's board of directors are considered experienced (4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 23:38
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangzhou LBP Medicine Science & Technology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution